US Patent Issued to PTC Therapeutics on April 22 for "2-substituted amino-naphth (1,2-d) imidazol-5-one compounds of pharmaceutically acceptable salts thereof" (Japanese Inventors)

ALEXANDRIA, Va., June 6 -- United States Patent no. 12,281,083, issued on April 22, was assigned to PTC Therapeutics Inc. (Warren, N.J.).

"2-substituted amino-naphth (1,2-d) imidazol-5-one compounds of pharmaceutically acceptable salts thereof" was invented by Hiroyuki Kitano (Osaka, Japan) and Kazuto Mori (Osaka, Japan).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided herein are therapeutic and/or prophylactic compounds for mitochondrial or oxidative stress diseases such as cancer, amyotropic lateral sclerosis, Creutzfeldt-Jakob disease, Machado-Joseph disease, spinocerebellar ataxia, Huntington disease, Parkinson disease, Alzheimer disease, myocardial infarction, cerebral infarction, diseases related...